Europe · Markets & Finance · This is Money

AstraZeneca takes a £1.5bn stake in US cancer drug developer as it steps up investment in America

Published by This is Money · United Kingdom 1 h ago

The British drugs company has ploughed £1.5bn into US pharma firm Summit Therapeutics as part of a cancer treatment research joint venture.

Read the full article on This is Money Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thisismoney.co.uk)

Also worth reading

Financial Times

Hegseth to slash top US officer roles by 20%

Temerario on-track: flat-out in Lamborghini’s ballistic V8 supercar

Reuters Markets

Tech stocks gain on Anthropic IPO optimism, offsetting high oil, yields

Forex Today: Focus shifts to US PCE, ADP, inflation in OZ and Chinese PMIs

Proactive Investors

AMD's World Labs deal points to a bigger chip bill for physical AI

Investors Chronicle

Redcentric streamlines its business after data centre sale